Operating Expenses Summary of Eurofins Scientific SE

Eurofins Scientific SE's latest annual operating expenses in 2023 was 73.6 Million EUR , down -98.01% from previous year.
Eurofins Scientific SE's latest quarterly operating expenses in 2024 Q2 was 190.25 Million EUR , down 0.0% from previous quarter.
Eurofins Scientific SE reported a annual operating expenses of 3.7 Billion EUR in annual operating expenses 2022, up 12.23% from previous year.
Eurofins Scientific SE reported a annual operating expenses of 3.29 Billion EUR in annual operating expenses 2021, up 14.32% from previous year.
Eurofins Scientific SE reported a quarterly operating expenses of 190.25 Million EUR for 2024 Q1, down -18.22% from previous quarter.
Eurofins Scientific SE reported a quarterly operating expenses of 181.4 Million EUR for 2023 Q1, up 32.89% from previous quarter.

Annual Operating Expenses Chart of Eurofins Scientific SE (2023 - 2002)

Historical Annual Operating Expenses of Eurofins Scientific SE (2023 - 2002)

Year	Operating Expenses	Operating Expenses Growth
2023	73.6 Million EUR	-98.01%
2022	3.7 Billion EUR	12.23%
2021	3.29 Billion EUR	14.32%
2020	2.88 Billion EUR	5.37%
2019	2.73 Billion EUR	30.72%
2018	2.09 Billion EUR	29.33%
2017	1.61 Billion EUR	19.14%
2016	1.35 Billion EUR	28.26%
2015	1.05 Billion EUR	35.26%
2014	783.56 Million EUR	15.83%
2013	676.46 Million EUR	19.66%
2012	565.3 Million EUR	27.34%
2011	443.93 Million EUR	-29.6%
2010	630.54 Million EUR	78.06%
2009	354.12 Million EUR	4.83%
2008	337.82 Million EUR	34.94%
2007	250.35 Million EUR	36.98%
2006	182.77 Million EUR	51.77%
2005	120.42 Million EUR	21.96%
2004	98.74 Million EUR	2.34%
2003	96.48 Million EUR	6.97%
2002	90.2 Million EUR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	190.25 Million EUR	0.0%
2024 Q1	190.25 Million EUR	-18.22%
2023 Q1	181.4 Million EUR	32.89%
2023 Q3	232.65 Million EUR	28.25%
2023 Q2	181.4 Million EUR	0.0%
2023 Q4	232.65 Million EUR	0.0%
2023 FY	73.6 Million EUR	-98.01%
2022 Q3	136.49 Million EUR	-25.88%
2022 Q4	136.49 Million EUR	0.0%
2022 FY	3.7 Billion EUR	12.23%
2022 Q1	184.15 Million EUR	-3.91%
2022 Q2	184.15 Million EUR	0.0%
2021 Q4	191.65 Million EUR	0.0%
2021 Q2	187.2 Million EUR	0.0%
2021 Q1	187.2 Million EUR	16.35%
2021 FY	3.29 Billion EUR	14.32%
2021 Q3	191.65 Million EUR	2.38%
2020 FY	2.88 Billion EUR	5.37%
2020 Q1	146.8 Million EUR	4.67%
2020 Q3	160.89 Million EUR	9.6%
2020 Q2	146.8 Million EUR	0.0%
2020 Q4	160.89 Million EUR	0.0%
2019 FY	2.73 Billion EUR	30.72%
2019 Q1	141.14 Million EUR	50.72%
2019 Q2	141.14 Million EUR	0.0%
2019 Q3	140.25 Million EUR	-0.64%
2019 Q4	140.25 Million EUR	0.0%
2018 Q1	88.95 Million EUR	42.55%
2018 FY	2.09 Billion EUR	29.33%
2018 Q2	88.95 Million EUR	0.0%
2018 Q3	93.64 Million EUR	5.28%
2018 Q4	93.64 Million EUR	0.0%
2017 Q3	62.39 Million EUR	-3.31%
2017 FY	1.61 Billion EUR	19.14%
2017 Q4	62.39 Million EUR	0.0%
2017 Q1	64.53 Million EUR	66.69%
2017 Q2	64.53 Million EUR	0.0%
2016 Q2	44.95 Million EUR	0.0%
2016 Q1	44.95 Million EUR	-10.5%
2016 Q3	38.71 Million EUR	-13.89%
2016 Q4	38.71 Million EUR	0.0%
2016 FY	1.35 Billion EUR	28.26%
2015 Q1	37.97 Million EUR	13.85%
2015 Q4	50.22 Million EUR	0.0%
2015 Q3	50.22 Million EUR	32.29%
2015 FY	1.05 Billion EUR	35.26%
2015 Q2	37.97 Million EUR	0.0%
2014 FY	783.56 Million EUR	15.83%
2014 Q3	33.35 Million EUR	6.52%
2014 Q1	31.31 Million EUR	45.62%
2014 Q2	31.31 Million EUR	0.0%
2014 Q4	33.35 Million EUR	0.0%
2013 Q1	25.66 Million EUR	38.37%
2013 FY	676.46 Million EUR	19.66%
2013 Q4	21.5 Million EUR	0.0%
2013 Q3	21.5 Million EUR	-16.21%
2013 Q2	25.66 Million EUR	0.0%
2012 Q2	- EUR	100.0%
2012 Q4	18.54 Million EUR	0.0%
2012 Q3	18.54 Million EUR	0.0%
2012 FY	565.3 Million EUR	27.34%
2012 Q1	-111.75 Thousand EUR	-100.09%
2011 Q3	112.1 Million EUR	-0.01%
2011 Q2	112.11 Million EUR	16.65%
2011 Q1	96.11 Million EUR	-82.13%
2011 FY	443.93 Million EUR	-29.6%
2011 Q4	123.6 Million EUR	10.26%
2010 FY	630.54 Million EUR	78.06%
2010 Q2	93.44 Million EUR	4.0%
2010 Q1	89.84 Million EUR	-66.1%
2010 Q3	276.02 Million EUR	195.39%
2010 Q4	537.81 Million EUR	94.85%
2009 Q3	265.61 Million EUR	199.4%
2009 Q1	87.79 Million EUR	35116300.0%
2009 Q4	265.01 Million EUR	-0.23%
2009 Q2	88.71 Million EUR	1.06%
2009 FY	354.12 Million EUR	4.83%
2008 Q4	250.00 EUR	0.0%
2008 FY	337.82 Million EUR	34.94%
2008 Q2	250.00 EUR	0.0%
2008 Q1	250.00 EUR	100.0%
2008 Q3	250.00 EUR	0.0%
2007 Q2	-62.08 Million EUR	0.0%
2007 Q1	-62.08 Million EUR	-35.98%
2007 FY	250.35 Million EUR	36.98%
2007 Q4	-62.08 Million EUR	0.0%
2007 Q3	-62.08 Million EUR	0.0%
2006 Q4	-45.65 Million EUR	0.0%
2006 FY	182.77 Million EUR	51.77%
2006 Q2	-45.65 Million EUR	0.0%
2006 Q1	-45.65 Million EUR	-3977.66%
2006 Q3	-45.65 Million EUR	0.0%
2005 Q2	1.17 Million EUR	0.0%
2005 FY	120.42 Million EUR	21.96%
2005 Q1	1.17 Million EUR	2881.01%
2005 Q4	1.17 Million EUR	0.0%
2005 Q3	1.17 Million EUR	0.0%
2004 Q1	39.5 Thousand EUR	-99.8%
2004 Q4	39.5 Thousand EUR	0.0%
2004 Q2	39.5 Thousand EUR	0.0%
2004 Q3	39.5 Thousand EUR	0.0%
2004 FY	98.74 Million EUR	2.34%
2003 Q2	19.48 Million EUR	0.0%
2003 Q4	19.48 Million EUR	0.0%
2003 FY	96.48 Million EUR	6.97%
2003 Q1	19.48 Million EUR	0.21%
2003 Q3	19.48 Million EUR	0.0%
2002 FY	90.2 Million EUR	0.0%
2002 Q2	19.44 Million EUR	0.0%
2002 Q3	19.44 Million EUR	0.0%
2002 Q4	19.44 Million EUR	0.0%
2002 Q1	19.44 Million EUR	0.0%

Peer Operating Expenses Comparison of Eurofins Scientific SE

Name	Operating Expenses	Operating Expenses Difference
Biosynex SA	86.53 Million EUR	14.949%
Predilife S.A.	4.14 Million EUR	-1673.782%
bioMérieux S.A.	1.44 Billion EUR	94.916%
Lumibird SA	115.93 Million EUR	36.517%

Global Stocks Search

Eurofins Scientific SE (ERF.PA)

Operating Expenses Summary of Eurofins Scientific SE

Annual Operating Expenses Chart of Eurofins Scientific SE (2023 - 2002)

Historical Annual Operating Expenses of Eurofins Scientific SE (2023 - 2002)

Peer Operating Expenses Comparison of Eurofins Scientific SE